Data as of Dec 12
| +0.01 / +0.53%|
The 4 analysts offering 12-month price forecasts for Catalyst Pharmaceutical Partners Inc have a median target of 4.50, with a high estimate of 6.00 and a low estimate of 3.75. The median estimate represents a +139.36% increase from the last price of 1.88.
The current consensus among 4 polled investment analysts is to Buy stock in Catalyst Pharmaceutical Partners Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.